Latest news with #Grinta
CairoScene
18-03-2025
- Business
- CairoScene
Egypt's Grinta Expands to Primary Care With Citi Clinic Acquisition
Egyptian pharma-tech startup Grinta is shifting its focus from B2B retail distribution to expand into primary healthcare. Mar 18, 2025 Egyptian healthtech startup Grinta has announced its acquisition of Citi Clinic, a primary healthcare service chain based in Egypt, marking a strategic shift from B2B pharmaceutical distribution to direct patient care. As part of this transition, Grinta has also secured a strategic funding round from Beltone Venture Capital and Raed Ventures, though the investment amount remains undisclosed. By acquiring Citi Clinic, Grinta gains access to a network of over 150,000 patients, integrating offline and online healthcare services. This move reflects a broader industry trend, with major pharmaceutical players like McKesson and Walgreens also transitioning into direct-to-consumer healthcare services. Beyond Egypt, Grinta is expanding its East African footprint, with plans to build a pharmacy chain in Tanzania and develop export partnerships with Egyptian pharmaceutical manufacturers.
Daily News Egypt
16-03-2025
- Business
- Daily News Egypt
Grinta acquires Citi Clinic, secures strategic investments from Beltone VC, Raed Ventures
Grinta, a leading healthcare and pharmaceutical solutions company, has announced its acquisition of Citi Clinic, one of Egypt's most successful primary healthcare service chains. Alongside this milestone, Grinta has secured an undisclosed amount of strategic investment in a funding round led by Beltone Venture Capital and Raed Ventures. The acquisition grants Grinta access to over 150,000 patients, marking its entry into the care sector and reinforcing its commitment to integrating both online and offline healthcare solutions. Mohamed Azab, Co-founder and CEO of Grinta, stated: 'The acquisition of Citi Clinic is a pivotal moment for Grinta. It not only enables us to enter the care market but also allows us to integrate offline and online services to transform the way healthcare is accessed and delivered. We are excited about what lies ahead as we expand our reach and impact.' This move aligns with a global trend of B2B pharmaceutical distributors expanding into direct-to-consumer (B2C) healthcare, following the successful models of companies like McKesson and Walgreens. Grinta aims to replicate this strategy by broadening its healthcare services across Egypt and East Africa. As part of its transformation, Grinta has exited its B2B retail pharmaceutical distribution business in Egypt to fully focus on patient care. The company is also expanding its presence in East Africa by partnering with Egyptian pharmaceutical manufacturers and launching a pharmacy chain in Tanzania through a buy-and-build strategy.
